Indeed, the NSCLC cells used in our study have different TP53 genotype (Supplementary Table 1), as reported in the literature (Mukhopadhyay and Roth, 1993; Deng et al., 2007; Tyagi et al., 2013; Pellerano et al., 2019). The gene discussed is TP53; the disease is non-small cell lung carcinoma.